Niels Gyldenkerne
Odense, 5000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort study.
Journal: Oral oncology
Published: October 10, 2025
Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: July 07, 2025
Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 09, 2024
Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a national DAHANCA cohort study.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 01, 2022
Delineation uncertainties of tumour volumes on MRI of head and neck cancer patients.
Journal: Clinical and translational radiation oncology
Published: March 22, 2022
Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 19, 2017
Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 04, 2017
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans.
Journal: Clinical and translational radiation oncology
Published: September 19, 2016
Trends in melanoma in the elderly in Denmark, 1980-2012.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 20, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026